$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| ASTRAZENECA PLC - BLOCKLISTING INTERIM REVIEW | 01 Jun 2015 |
| UPDATE ON BRODALUMAB DEVELOPMENT PROGRAMME | 26 May 2015 |
| HOLDING(S) IN COMPANY | 13 May 2015 |
| DIRECTOR/PDMR SHAREHOLDING | 08 May 2015 |
| DIRECTOR/PDMR SHAREHOLDING | 08 May 2015 |
| DIRECTOR DECLARATION | 07 May 2015 |
| TOTAL VOTING RIGHTS | 01 May 2015 |
| DIRECTOR/PDMR SHAREHOLDING | 01 May 2015 |
| DIRECTOR/PDMR SHAREHOLDING | 29 Apr 2015 |
| AZ AND INNATE TO COLLABORATE IN IMMUNO-ONCOLOGY | 24 Apr 2015 |
| RESULT OF AGM | 24 Apr 2015 |
| 1ST QUARTER RESULTS | 24 Apr 2015 |
| COLLABORATION WITH CELGENE ON PD-L1 IN HAEMATOLOGY | 24 Apr 2015 |
| NOTICE OF RESULTS | 23 Apr 2015 |
| SELUMETINIB GRANTED ORPHAN DRUG DESIGNATION BY FDA | 17 Apr 2015 |
| TREMELIMUMAB GRANTED ORPHAN DRUG DESIGNATION | 15 Apr 2015 |
| FDA REVIEWS SAVOR OUTCOMES STUDY RESULTS | 15 Apr 2015 |
| TOTAL VOTING RIGHTS | 01 Apr 2015 |
| DIRECTOR/PDMR SHAREHOLDING | 30 Mar 2015 |
| NOTICE OF AGM | 19 Mar 2015 |
